APO Research
Talk to an analyst

APO RESEARCH · REPORT

Propofol Injection for Operation General Anesthesia

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Propofol Injection for Operation General Anesthesia Market Analysis and Forecast 2026-2032

22 December 2025195 pages

Choose your research edition.

Industry ResearchPropofol Injection for Operation General Anesthesia Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Propofol Injection for Operation General Anesthesia Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Propofol Injection for Operation General Anesthesia Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Propofol Injection for Operation General Anesthesia Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Propofol Injection for Operation General Anesthesia Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Propofol Injection for Operation General Anesthesia market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Propofol Injection for Operation General Anesthesia is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Propofol Injection for Operation General Anesthesia is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Propofol Injection for Operation General Anesthesia is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Propofol Injection for Operation General Anesthesia is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Propofol Injection for Operation General Anesthesia include Yichang Humanwell, Xi'an Libang, Nhwa, Hengrui, China National Medicines Guorui Pharmaceutical Co.,Ltd., Fresenius-Kabi, Baxter Healthcare, AbbVie and AstraZeneca, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Propofol Injection for Operation General Anesthesia, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Propofol Injection for Operation General Anesthesia, also provides the sales of main regions and countries. Of the upcoming market potential for Propofol Injection for Operation General Anesthesia, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Propofol Injection for Operation General Anesthesia sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Propofol Injection for Operation General Anesthesia market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Propofol Injection for Operation General Anesthesia sales, projected growth trends, production technology, application and end-user industry.

Propofol Injection for Operation General Anesthesia Segment by Company

Yichang Humanwell

Xi'an Libang

Nhwa

Hengrui

China National Medicines Guorui Pharmaceutical Co.,Ltd.

Fresenius-Kabi

Baxter Healthcare

AbbVie

AstraZeneca

Piramal

Maruishi

Hikma Pharmaceuticals

B.Braun

Aspen Pharma

Propofol Injection for Operation General Anesthesia Segment by Type

10ml

20ml

50ml

Others

Propofol Injection for Operation General Anesthesia Segment by Application

Hopitals

Clinics

Others

Propofol Injection for Operation General Anesthesia Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Propofol Injection for Operation General Anesthesia market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Propofol Injection for Operation General Anesthesia and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Propofol Injection for Operation General Anesthesia.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Propofol Injection for Operation General Anesthesia in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Propofol Injection for Operation General Anesthesia manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Propofol Injection for Operation General Anesthesia sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Propofol Injection for Operation General Anesthesia Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 10ml Major Manufacturers Table 3. 20ml Major Manufacturers Table 4. 50ml Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Propofol Injection for Operation General Anesthesia Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hopitals Major Manufacturers Table 8. Clinics Major Manufacturers Table 9. Others Major Manufacturers Table 10. Propofol Injection for Operation General Anesthesia Industry Trends Table 11. Propofol Injection for Operation General Anesthesia Industry Drivers Table 12. Propofol Injection for Operation General Anesthesia Industry Opportunities and Challenges Table 13. Propofol Injection for Operation General Anesthesia Industry Restraints Table 14. Global Propofol Injection for Operation General Anesthesia Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Propofol Injection for Operation General Anesthesia Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Propofol Injection for Operation General Anesthesia Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Region (2021-2026) Table 18. Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Region (2027-2032) Table 19. Global Propofol Injection for Operation General Anesthesia Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 20. Global Propofol Injection for Operation General Anesthesia Sales by Region (2021-2026) & (k units) Table 21. Global Propofol Injection for Operation General Anesthesia Sales by Region (2027-2032) & (k units) Table 22. Global Propofol Injection for Operation General Anesthesia Sales Market Share by Region (2021-2026) Table 23. Global Propofol Injection for Operation General Anesthesia Sales Market Share by Region (2027-2032) Table 24. Global Propofol Injection for Operation General Anesthesia Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Propofol Injection for Operation General Anesthesia Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Propofol Injection for Operation General Anesthesia Sales Market Share by Manufacturers (2021-2026) Table 28. Global Propofol Injection for Operation General Anesthesia Sales Price (US$/unit) of Manufacturers (2021-2026) Table 29. Global Propofol Injection for Operation General Anesthesia Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Propofol Injection for Operation General Anesthesia Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Propofol Injection for Operation General Anesthesia Manufacturers, Product Type & Application Table 32. Global Propofol Injection for Operation General Anesthesia Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Propofol Injection for Operation General Anesthesia by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Propofol Injection for Operation General Anesthesia Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Propofol Injection for Operation General Anesthesia Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Propofol Injection for Operation General Anesthesia Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Type (2021-2026) Table 39. Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Type (2027-2032) Table 40. Global Propofol Injection for Operation General Anesthesia Sales by Type 2021 VS 2025 VS 2032 (k units) Table 41. Global Propofol Injection for Operation General Anesthesia Sales by Type (2021-2026) & (k units) Table 42. Global Propofol Injection for Operation General Anesthesia Sales by Type (2027-2032) & (k units) Table 43. Global Propofol Injection for Operation General Anesthesia Sales Market Share by Type (2021-2026) Table 44. Global Propofol Injection for Operation General Anesthesia Sales Market Share by Type (2027-2032) Table 45. Global Propofol Injection for Operation General Anesthesia Price by Type (2021-2026) & (US$/unit) Table 46. Global Propofol Injection for Operation General Anesthesia Price by Type (2027-2032) & (US$/unit) Table 47. Global Propofol Injection for Operation General Anesthesia Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Propofol Injection for Operation General Anesthesia Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Propofol Injection for Operation General Anesthesia Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Application (2021-2026) Table 51. Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Application (2027-2032) Table 52. Global Propofol Injection for Operation General Anesthesia Sales by Application 2021 VS 2025 VS 2032 (k units) Table 53. Global Propofol Injection for Operation General Anesthesia Sales by Application (2021-2026) & (k units) Table 54. Global Propofol Injection for Operation General Anesthesia Sales by Application (2027-2032) & (k units) Table 55. Global Propofol Injection for Operation General Anesthesia Sales Market Share by Application (2021-2026) Table 56. Global Propofol Injection for Operation General Anesthesia Sales Market Share by Application (2027-2032) Table 57. Global Propofol Injection for Operation General Anesthesia Price by Application (2021-2026) & (US$/unit) Table 58. Global Propofol Injection for Operation General Anesthesia Price by Application (2027-2032) & (US$/unit) Table 59. Yichang Humanwell Company Information Table 60. Yichang Humanwell Business Overview Table 61. Yichang Humanwell Propofol Injection for Operation General Anesthesia Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 62. Yichang Humanwell Propofol Injection for Operation General Anesthesia Product Portfolio Table 63. Yichang Humanwell Recent Development Table 64. Xi'an Libang Company Information Table 65. Xi'an Libang Business Overview Table 66. Xi'an Libang Propofol Injection for Operation General Anesthesia Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Xi'an Libang Propofol Injection for Operation General Anesthesia Product Portfolio Table 68. Xi'an Libang Recent Development Table 69. Nhwa Company Information Table 70. Nhwa Business Overview Table 71. Nhwa Propofol Injection for Operation General Anesthesia Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Nhwa Propofol Injection for Operation General Anesthesia Product Portfolio Table 73. Nhwa Recent Development Table 74. Hengrui Company Information Table 75. Hengrui Business Overview Table 76. Hengrui Propofol Injection for Operation General Anesthesia Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Hengrui Propofol Injection for Operation General Anesthesia Product Portfolio Table 78. Hengrui Recent Development Table 79. China National Medicines Guorui Pharmaceutical Co.,Ltd. Company Information Table 80. China National Medicines Guorui Pharmaceutical Co.,Ltd. Business Overview Table 81. China National Medicines Guorui Pharmaceutical Co.,Ltd. Propofol Injection for Operation General Anesthesia Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. China National Medicines Guorui Pharmaceutical Co.,Ltd. Propofol Injection for Operation General Anesthesia Product Portfolio Table 83. China National Medicines Guorui Pharmaceutical Co.,Ltd. Recent Development Table 84. Fresenius-Kabi Company Information Table 85. Fresenius-Kabi Business Overview Table 86. Fresenius-Kabi Propofol Injection for Operation General Anesthesia Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Fresenius-Kabi Propofol Injection for Operation General Anesthesia Product Portfolio Table 88. Fresenius-Kabi Recent Development Table 89. Baxter Healthcare Company Information Table 90. Baxter Healthcare Business Overview Table 91. Baxter Healthcare Propofol Injection for Operation General Anesthesia Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Baxter Healthcare Propofol Injection for Operation General Anesthesia Product Portfolio Table 93. Baxter Healthcare Recent Development Table 94. AbbVie Company Information Table 95. AbbVie Business Overview Table 96. AbbVie Propofol Injection for Operation General Anesthesia Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. AbbVie Propofol Injection for Operation General Anesthesia Product Portfolio Table 98. AbbVie Recent Development Table 99. AstraZeneca Company Information Table 100. AstraZeneca Business Overview Table 101. AstraZeneca Propofol Injection for Operation General Anesthesia Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. AstraZeneca Propofol Injection for Operation General Anesthesia Product Portfolio Table 103. AstraZeneca Recent Development Table 104. Piramal Company Information Table 105. Piramal Business Overview Table 106. Piramal Propofol Injection for Operation General Anesthesia Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Piramal Propofol Injection for Operation General Anesthesia Product Portfolio Table 108. Piramal Recent Development Table 109. Maruishi Company Information Table 110. Maruishi Business Overview Table 111. Maruishi Propofol Injection for Operation General Anesthesia Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Maruishi Propofol Injection for Operation General Anesthesia Product Portfolio Table 113. Maruishi Recent Development Table 114. Hikma Pharmaceuticals Company Information Table 115. Hikma Pharmaceuticals Business Overview Table 116. Hikma Pharmaceuticals Propofol Injection for Operation General Anesthesia Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Hikma Pharmaceuticals Propofol Injection for Operation General Anesthesia Product Portfolio Table 118. Hikma Pharmaceuticals Recent Development Table 119. B.Braun Company Information Table 120. B.Braun Business Overview Table 121. B.Braun Propofol Injection for Operation General Anesthesia Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. B.Braun Propofol Injection for Operation General Anesthesia Product Portfolio Table 123. B.Braun Recent Development Table 124. Aspen Pharma Company Information Table 125. Aspen Pharma Business Overview Table 126. Aspen Pharma Propofol Injection for Operation General Anesthesia Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 127. Aspen Pharma Propofol Injection for Operation General Anesthesia Product Portfolio Table 128. Aspen Pharma Recent Development Table 129. North America Propofol Injection for Operation General Anesthesia Revenue by Type (2021-2026) & (US$ Million) Table 130. North America Propofol Injection for Operation General Anesthesia Revenue by Type (2027-2032) & (US$ Million) Table 131. North America Propofol Injection for Operation General Anesthesia Sales by Type (2021-2026) & (k units) Table 132. North America Propofol Injection for Operation General Anesthesia Sales by Type (2027-2032) & (k units) Table 133. North America Propofol Injection for Operation General Anesthesia Sales Price by Type (2021-2026) & (US$/unit) Table 134. North America Propofol Injection for Operation General Anesthesia Sales Price by Type (2027-2032) & (US$/unit) Table 135. North America Propofol Injection for Operation General Anesthesia Revenue by Application (2021-2026) & (US$ Million) Table 136. North America Propofol Injection for Operation General Anesthesia Revenue by Application (2027-2032) & (US$ Million) Table 137. North America Propofol Injection for Operation General Anesthesia Sales by Application (2021-2026) & (k units) Table 138. North America Propofol Injection for Operation General Anesthesia Sales by Application (2027-2032) & (k units) Table 139. North America Propofol Injection for Operation General Anesthesia Sales Price by Application (2021-2026) & (US$/unit) Table 140. North America Propofol Injection for Operation General Anesthesia Sales Price by Application (2027-2032) & (US$/unit) Table 141. North America Propofol Injection for Operation General Anesthesia Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. North America Propofol Injection for Operation General Anesthesia Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 143. North America Propofol Injection for Operation General Anesthesia Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 144. North America Propofol Injection for Operation General Anesthesia Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 145. North America Propofol Injection for Operation General Anesthesia Sales by Country (2021-2026) & (k units) Table 146. North America Propofol Injection for Operation General Anesthesia Sales by Country (2027-2032) & (k units) Table 147. North America Propofol Injection for Operation General Anesthesia Sales Price by Country (2021-2026) & (US$/unit) Table 148. North America Propofol Injection for Operation General Anesthesia Sales Price by Country (2027-2032) & (US$/unit) Table 149. United States Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Table 150. Canada Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Table 151. Mexico Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Table 152. Europe Propofol Injection for Operation General Anesthesia Revenue by Type (2021-2026) & (US$ Million) Table 153. Europe Propofol Injection for Operation General Anesthesia Revenue by Type (2027-2032) & (US$ Million) Table 154. Europe Propofol Injection for Operation General Anesthesia Sales by Type (2021-2026) & (k units) Table 155. Europe Propofol Injection for Operation General Anesthesia Sales by Type (2027-2032) & (k units) Table 156. Europe Propofol Injection for Operation General Anesthesia Sales Price by Type (2021-2026) & (US$/unit) Table 157. Europe Propofol Injection for Operation General Anesthesia Sales Price by Type (2027-2032) & (US$/unit) Table 158. Europe Propofol Injection for Operation General Anesthesia Revenue by Application (2021-2026) & (US$ Million) Table 159. Europe Propofol Injection for Operation General Anesthesia Revenue by Application (2027-2032) & (US$ Million) Table 160. Europe Propofol Injection for Operation General Anesthesia Sales by Application (2021-2026) & (k units) Table 161. Europe Propofol Injection for Operation General Anesthesia Sales by Application (2027-2032) & (k units) Table 162. Europe Propofol Injection for Operation General Anesthesia Sales Price by Application (2021-2026) & (US$/unit) Table 163. Europe Propofol Injection for Operation General Anesthesia Sales Price by Application (2027-2032) & (US$/unit) Table 164. Europe Propofol Injection for Operation General Anesthesia Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. Europe Propofol Injection for Operation General Anesthesia Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. Europe Propofol Injection for Operation General Anesthesia Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. Europe Propofol Injection for Operation General Anesthesia Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 168. Europe Propofol Injection for Operation General Anesthesia Sales by Country (2021-2026) & (k units) Table 169. Europe Propofol Injection for Operation General Anesthesia Sales by Country (2027-2032) & (k units) Table 170. Europe Propofol Injection for Operation General Anesthesia Sales Price by Country (2021-2026) & (US$/unit) Table 171. Europe Propofol Injection for Operation General Anesthesia Sales Price by Country (2027-2032) & (US$/unit) Table 172. Germany Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Table 173. France Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Table 174. U.K. Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Table 175. Italy Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Table 176. Russia Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Table 177. Spain Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Table 178. Netherlands Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Table 179. Switzerland Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Table 180. Sweden Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Table 181. Poland Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Table 182. China Propofol Injection for Operation General Anesthesia Revenue by Type (2021-2026) & (US$ Million) Table 183. China Propofol Injection for Operation General Anesthesia Revenue by Type (2027-2032) & (US$ Million) Table 184. China Propofol Injection for Operation General Anesthesia Sales by Type (2021-2026) & (k units) Table 185. China Propofol Injection for Operation General Anesthesia Sales by Type (2027-2032) & (k units) Table 186. China Propofol Injection for Operation General Anesthesia Sales Price by Type (2021-2026) & (US$/unit) Table 187. China Propofol Injection for Operation General Anesthesia Sales Price by Type (2027-2032) & (US$/unit) Table 188. China Propofol Injection for Operation General Anesthesia Revenue by Application (2021-2026) & (US$ Million) Table 189. China Propofol Injection for Operation General Anesthesia Revenue by Application (2027-2032) & (US$ Million) Table 190. China Propofol Injection for Operation General Anesthesia Sales by Application (2021-2026) & (k units) Table 191. China Propofol Injection for Operation General Anesthesia Sales by Application (2027-2032) & (k units) Table 192. China Propofol Injection for Operation General Anesthesia Sales Price by Application (2021-2026) & (US$/unit) Table 193. China Propofol Injection for Operation General Anesthesia Sales Price by Application (2027-2032) & (US$/unit) Table 194. Asia Propofol Injection for Operation General Anesthesia Revenue by Type (2021-2026) & (US$ Million) Table 195. Asia Propofol Injection for Operation General Anesthesia Revenue by Type (2027-2032) & (US$ Million) Table 196. Asia Propofol Injection for Operation General Anesthesia Sales by Type (2021-2026) & (k units) Table 197. Asia Propofol Injection for Operation General Anesthesia Sales by Type (2027-2032) & (k units) Table 198. Asia Propofol Injection for Operation General Anesthesia Sales Price by Type (2021-2026) & (US$/unit) Table 199. Asia Propofol Injection for Operation General Anesthesia Sales Price by Type (2027-2032) & (US$/unit) Table 200. Asia Propofol Injection for Operation General Anesthesia Revenue by Application (2021-2026) & (US$ Million) Table 201. Asia Propofol Injection for Operation General Anesthesia Revenue by Application (2027-2032) & (US$ Million) Table 202. Asia Propofol Injection for Operation General Anesthesia Sales by Application (2021-2026) & (k units) Table 203. Asia Propofol Injection for Operation General Anesthesia Sales by Application (2027-2032) & (k units) Table 204. Asia Propofol Injection for Operation General Anesthesia Sales Price by Application (2021-2026) & (US$/unit) Table 205. Asia Propofol Injection for Operation General Anesthesia Sales Price by Application (2027-2032) & (US$/unit) Table 206. Asia Propofol Injection for Operation General Anesthesia Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 207. Asia Propofol Injection for Operation General Anesthesia Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 208. Asia Propofol Injection for Operation General Anesthesia Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 209. Asia Propofol Injection for Operation General Anesthesia Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 210. Asia Propofol Injection for Operation General Anesthesia Sales by Country (2021-2026) & (k units) Table 211. Asia Propofol Injection for Operation General Anesthesia Sales by Country (2027-2032) & (k units) Table 212. Asia Propofol Injection for Operation General Anesthesia Sales Price by Country (2021-2026) & (US$/unit) Table 213. Asia Propofol Injection for Operation General Anesthesia Sales Price by Country (2027-2032) & (US$/unit) Table 214. Japan Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Table 215. South Korea Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Table 216. India Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Table 217. Australia Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Table 218. Taiwan Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Table 219. Southeast Asia Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Table 220. SAMEA Propofol Injection for Operation General Anesthesia Revenue by Type (2021-2026) & (US$ Million) Table 221. SAMEA Propofol Injection for Operation General Anesthesia Revenue by Type (2027-2032) & (US$ Million) Table 222. SAMEA Propofol Injection for Operation General Anesthesia Sales by Type (2021-2026) & (k units) Table 223. SAMEA Propofol Injection for Operation General Anesthesia Sales by Type (2027-2032) & (k units) Table 224. SAMEA Propofol Injection for Operation General Anesthesia Sales Price by Type (2021-2026) & (US$/unit) Table 225. SAMEA Propofol Injection for Operation General Anesthesia Sales Price by Type (2027-2032) & (US$/unit) Table 226. SAMEA Propofol Injection for Operation General Anesthesia Revenue by Application (2021-2026) & (US$ Million) Table 227. SAMEA Propofol Injection for Operation General Anesthesia Revenue by Application (2027-2032) & (US$ Million) Table 228. SAMEA Propofol Injection for Operation General Anesthesia Sales by Application (2021-2026) & (k units) Table 229. SAMEA Propofol Injection for Operation General Anesthesia Sales by Application (2027-2032) & (k units) Table 230. SAMEA Propofol Injection for Operation General Anesthesia Sales Price by Application (2021-2026) & (US$/unit) Table 231. SAMEA Propofol Injection for Operation General Anesthesia Sales Price by Application (2027-2032) & (US$/unit) Table 232. SAMEA Propofol Injection for Operation General Anesthesia Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 233. SAMEA Propofol Injection for Operation General Anesthesia Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 234. SAMEA Propofol Injection for Operation General Anesthesia Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 235. SAMEA Propofol Injection for Operation General Anesthesia Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 236. SAMEA Propofol Injection for Operation General Anesthesia Sales by Country (2021-2026) & (k units) Table 237. SAMEA Propofol Injection for Operation General Anesthesia Sales by Country (2027-2032) & (k units) Table 238. SAMEA Propofol Injection for Operation General Anesthesia Sales Price by Country (2021-2026) & (US$/unit) Table 239. SAMEA Propofol Injection for Operation General Anesthesia Sales Price by Country (2027-2032) & (US$/unit) Table 240. Brazil Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Table 241. Argentina Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Table 242. Chile Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Table 243. Colombia Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Table 244. Peru Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Table 245. Saudi Arabia Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Table 246. Israel Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Table 247. UAE Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Table 248. Turkey Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Table 249. Iran Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Table 250. Egypt Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Table 251. Key Raw Materials Table 252. Raw Materials Key Suppliers Table 253. Propofol Injection for Operation General Anesthesia Distributors List Table 254. Propofol Injection for Operation General Anesthesia Customers List Table 255. Research Programs/Design for This Report Table 256. Authors List of This Report Table 257. Secondary Sources Table 258. Primary Sources List of Figures Figure 1. Propofol Injection for Operation General Anesthesia Image Figure 2. Global Propofol Injection for Operation General Anesthesia Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Propofol Injection for Operation General Anesthesia Market Size Share 2021 VS 2025 VS 2032 Figure 4. 10ml Image Figure 5. 20ml Image Figure 6. 50ml Image Figure 7. Others Image Figure 8. Global Propofol Injection for Operation General Anesthesia Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Propofol Injection for Operation General Anesthesia Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hopitals Image Figure 11. Clinics Image Figure 12. Others Image Figure 13. Global Propofol Injection for Operation General Anesthesia Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Figure 15. Global Propofol Injection for Operation General Anesthesia Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Region (2021-2032) Figure 18. Global Propofol Injection for Operation General Anesthesia Sales (2021-2032) & (k units) Figure 19. Global Propofol Injection for Operation General Anesthesia Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 20. Global Propofol Injection for Operation General Anesthesia Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Propofol Injection for Operation General Anesthesia Sales YoY (2021-2032) & (k units) Figure 22. Europe Propofol Injection for Operation General Anesthesia Sales YoY (2021-2032) & (k units) Figure 23. China Propofol Injection for Operation General Anesthesia Sales YoY (2021-2032) & (k units) Figure 24. Asia (Excluding China) Propofol Injection for Operation General Anesthesia Sales YoY (2021-2032) & (k units) Figure 25. South America, Middle East and Africa Propofol Injection for Operation General Anesthesia Sales YoY (2021-2032) & (k units) Figure 26. Global Propofol Injection for Operation General Anesthesia Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Propofol Injection for Operation General Anesthesia Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Propofol Injection for Operation General Anesthesia Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Type (2021-2032) Figure 32. Global Propofol Injection for Operation General Anesthesia Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 33. Global Propofol Injection for Operation General Anesthesia Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Propofol Injection for Operation General Anesthesia Sales Market Share by Type (2021-2032) Figure 35. Global Propofol Injection for Operation General Anesthesia Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Application (2021-2032) Figure 38. Global Propofol Injection for Operation General Anesthesia Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 39. Global Propofol Injection for Operation General Anesthesia Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Propofol Injection for Operation General Anesthesia Sales Market Share by Application (2021-2032) Figure 41. North America Propofol Injection for Operation General Anesthesia Revenue Share by Type (2021-2032) Figure 42. North America Propofol Injection for Operation General Anesthesia Sales Share by Type (2021-2032) Figure 43. North America Propofol Injection for Operation General Anesthesia Revenue Share by Application (2021-2032) Figure 44. North America Propofol Injection for Operation General Anesthesia Sales Share by Application (2021-2032) Figure 45. North America Propofol Injection for Operation General Anesthesia Revenue Share by Country (2021-2032) Figure 46. North America Propofol Injection for Operation General Anesthesia Sales Share by Country (2021-2032) Figure 47. Europe Propofol Injection for Operation General Anesthesia Revenue Share by Type (2021-2032) Figure 48. Europe Propofol Injection for Operation General Anesthesia Sales Share by Type (2021-2032) Figure 49. Europe Propofol Injection for Operation General Anesthesia Revenue Share by Application (2021-2032) Figure 50. Europe Propofol Injection for Operation General Anesthesia Sales Share by Application (2021-2032) Figure 51. Europe Propofol Injection for Operation General An

Scope & coverage.

Types
  • 10ml
  • 20ml
  • 50ml
  • Others
Applications
  • Hopitals
  • Clinics
  • Others
Companies covered
  • Yichang Humanwell
  • Xi'an Libang
  • Nhwa
  • Hengrui
  • China National Medicines Guorui Pharmaceutical Co.,Ltd.
  • Fresenius-Kabi
  • Baxter Healthcare
  • AbbVie
  • AstraZeneca
  • Piramal
  • Maruishi
  • Hikma Pharmaceuticals
  • B.Braun
  • Aspen Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Propofol Injection for Operation General Anesthesia Market by Type
  3. 1.2.1 Global Propofol Injection for Operation General Anesthesia Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 10ml
  5. 1.2.3 20ml
  6. 1.2.4 50ml
  7. 1.2.5 Others
  8. 1.3 Propofol Injection for Operation General Anesthesia Market by Application
  9. 1.3.1 Global Propofol Injection for Operation General Anesthesia Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hopitals
  11. 1.3.3 Clinics
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Propofol Injection for Operation General Anesthesia Market Dynamics
  1. 2.1 Propofol Injection for Operation General Anesthesia Industry Trends
  2. 2.2 Propofol Injection for Operation General Anesthesia Industry Drivers
  3. 2.3 Propofol Injection for Operation General Anesthesia Industry Opportunities and Challenges
  4. 2.4 Propofol Injection for Operation General Anesthesia Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Propofol Injection for Operation General Anesthesia Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Propofol Injection for Operation General Anesthesia Revenue by Region
  3. 3.2.1 Global Propofol Injection for Operation General Anesthesia Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Propofol Injection for Operation General Anesthesia Revenue by Region (2021-2026)
  5. 3.2.3 Global Propofol Injection for Operation General Anesthesia Revenue by Region (2027-2032)
  6. 3.2.4 Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Propofol Injection for Operation General Anesthesia Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Propofol Injection for Operation General Anesthesia Sales by Region
  9. 3.4.1 Global Propofol Injection for Operation General Anesthesia Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Propofol Injection for Operation General Anesthesia Sales by Region (2021-2026)
  11. 3.4.3 Global Propofol Injection for Operation General Anesthesia Sales by Region (2027-2032)
  12. 3.4.4 Global Propofol Injection for Operation General Anesthesia Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Propofol Injection for Operation General Anesthesia Revenue by Manufacturers
  2. 4.1.1 Global Propofol Injection for Operation General Anesthesia Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Propofol Injection for Operation General Anesthesia Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Propofol Injection for Operation General Anesthesia Sales by Manufacturers
  6. 4.2.1 Global Propofol Injection for Operation General Anesthesia Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Propofol Injection for Operation General Anesthesia Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Propofol Injection for Operation General Anesthesia Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Propofol Injection for Operation General Anesthesia Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Propofol Injection for Operation General Anesthesia Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Propofol Injection for Operation General Anesthesia Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Propofol Injection for Operation General Anesthesia Manufacturers, Product Type & Application
  13. 4.7 Global Propofol Injection for Operation General Anesthesia Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Propofol Injection for Operation General Anesthesia Market CR5 and HHI
  16. 4.8.2 2025 Propofol Injection for Operation General Anesthesia Tier 1, Tier 2, and Tier 3
5 Propofol Injection for Operation General Anesthesia Market by Type
  1. 5.1 Global Propofol Injection for Operation General Anesthesia Revenue by Type
  2. 5.1.1 Global Propofol Injection for Operation General Anesthesia Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Propofol Injection for Operation General Anesthesia Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Propofol Injection for Operation General Anesthesia Sales by Type
  6. 5.2.1 Global Propofol Injection for Operation General Anesthesia Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Propofol Injection for Operation General Anesthesia Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Propofol Injection for Operation General Anesthesia Sales Market Share by Type (2021-2032)
  9. 5.3 Global Propofol Injection for Operation General Anesthesia Price by Type
6 Propofol Injection for Operation General Anesthesia Market by Application
  1. 6.1 Global Propofol Injection for Operation General Anesthesia Revenue by Application
  2. 6.1.1 Global Propofol Injection for Operation General Anesthesia Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Propofol Injection for Operation General Anesthesia Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Propofol Injection for Operation General Anesthesia Sales by Application
  6. 6.2.1 Global Propofol Injection for Operation General Anesthesia Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Propofol Injection for Operation General Anesthesia Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Propofol Injection for Operation General Anesthesia Sales Market Share by Application (2021-2032)
  9. 6.3 Global Propofol Injection for Operation General Anesthesia Price by Application
7 Company Profiles
  1. 7.1 Yichang Humanwell
  2. 7.1.1 Yichang Humanwell Company Information
  3. 7.1.2 Yichang Humanwell Business Overview
  4. 7.1.3 Yichang Humanwell Propofol Injection for Operation General Anesthesia Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Yichang Humanwell Propofol Injection for Operation General Anesthesia Product Portfolio
  6. 7.1.5 Yichang Humanwell Recent Developments
  7. 7.2 Xi'an Libang
  8. 7.2.1 Xi'an Libang Company Information
  9. 7.2.2 Xi'an Libang Business Overview
  10. 7.2.3 Xi'an Libang Propofol Injection for Operation General Anesthesia Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Xi'an Libang Propofol Injection for Operation General Anesthesia Product Portfolio
  12. 7.2.5 Xi'an Libang Recent Developments
  13. 7.3 Nhwa
  14. 7.3.1 Nhwa Company Information
  15. 7.3.2 Nhwa Business Overview
  16. 7.3.3 Nhwa Propofol Injection for Operation General Anesthesia Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Nhwa Propofol Injection for Operation General Anesthesia Product Portfolio
  18. 7.3.5 Nhwa Recent Developments
  19. 7.4 Hengrui
  20. 7.4.1 Hengrui Company Information
  21. 7.4.2 Hengrui Business Overview
  22. 7.4.3 Hengrui Propofol Injection for Operation General Anesthesia Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Hengrui Propofol Injection for Operation General Anesthesia Product Portfolio
  24. 7.4.5 Hengrui Recent Developments
  25. 7.5 China National Medicines Guorui Pharmaceutical Co.,Ltd.
  26. 7.5.1 China National Medicines Guorui Pharmaceutical Co.,Ltd. Company Information
  27. 7.5.2 China National Medicines Guorui Pharmaceutical Co.,Ltd. Business Overview
  28. 7.5.3 China National Medicines Guorui Pharmaceutical Co.,Ltd. Propofol Injection for Operation General Anesthesia Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 China National Medicines Guorui Pharmaceutical Co.,Ltd. Propofol Injection for Operation General Anesthesia Product Portfolio
  30. 7.5.5 China National Medicines Guorui Pharmaceutical Co.,Ltd. Recent Developments
  31. 7.6 Fresenius-Kabi
  32. 7.6.1 Fresenius-Kabi Company Information
  33. 7.6.2 Fresenius-Kabi Business Overview
  34. 7.6.3 Fresenius-Kabi Propofol Injection for Operation General Anesthesia Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Fresenius-Kabi Propofol Injection for Operation General Anesthesia Product Portfolio
  36. 7.6.5 Fresenius-Kabi Recent Developments
  37. 7.7 Baxter Healthcare
  38. 7.7.1 Baxter Healthcare Company Information
  39. 7.7.2 Baxter Healthcare Business Overview
  40. 7.7.3 Baxter Healthcare Propofol Injection for Operation General Anesthesia Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Baxter Healthcare Propofol Injection for Operation General Anesthesia Product Portfolio
  42. 7.7.5 Baxter Healthcare Recent Developments
  43. 7.8 AbbVie
  44. 7.8.1 AbbVie Company Information
  45. 7.8.2 AbbVie Business Overview
  46. 7.8.3 AbbVie Propofol Injection for Operation General Anesthesia Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 AbbVie Propofol Injection for Operation General Anesthesia Product Portfolio
  48. 7.8.5 AbbVie Recent Developments
  49. 7.9 AstraZeneca
  50. 7.9.1 AstraZeneca Company Information
  51. 7.9.2 AstraZeneca Business Overview
  52. 7.9.3 AstraZeneca Propofol Injection for Operation General Anesthesia Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 AstraZeneca Propofol Injection for Operation General Anesthesia Product Portfolio
  54. 7.9.5 AstraZeneca Recent Developments
  55. 7.10 Piramal
  56. 7.10.1 Piramal Company Information
  57. 7.10.2 Piramal Business Overview
  58. 7.10.3 Piramal Propofol Injection for Operation General Anesthesia Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Piramal Propofol Injection for Operation General Anesthesia Product Portfolio
  60. 7.10.5 Piramal Recent Developments
  61. 7.11 Maruishi
  62. 7.11.1 Maruishi Company Information
  63. 7.11.2 Maruishi Business Overview
  64. 7.11.3 Maruishi Propofol Injection for Operation General Anesthesia Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Maruishi Propofol Injection for Operation General Anesthesia Product Portfolio
  66. 7.11.5 Maruishi Recent Developments
  67. 7.12 Hikma Pharmaceuticals
  68. 7.12.1 Hikma Pharmaceuticals Company Information
  69. 7.12.2 Hikma Pharmaceuticals Business Overview
  70. 7.12.3 Hikma Pharmaceuticals Propofol Injection for Operation General Anesthesia Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Hikma Pharmaceuticals Propofol Injection for Operation General Anesthesia Product Portfolio
  72. 7.12.5 Hikma Pharmaceuticals Recent Developments
  73. 7.13 B.Braun
  74. 7.13.1 B.Braun Company Information
  75. 7.13.2 B.Braun Business Overview
  76. 7.13.3 B.Braun Propofol Injection for Operation General Anesthesia Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 B.Braun Propofol Injection for Operation General Anesthesia Product Portfolio
  78. 7.13.5 B.Braun Recent Developments
  79. 7.14 Aspen Pharma
  80. 7.14.1 Aspen Pharma Company Information
  81. 7.14.2 Aspen Pharma Business Overview
  82. 7.14.3 Aspen Pharma Propofol Injection for Operation General Anesthesia Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Aspen Pharma Propofol Injection for Operation General Anesthesia Product Portfolio
  84. 7.14.5 Aspen Pharma Recent Developments
8 North America
  1. 8.1 North America Propofol Injection for Operation General Anesthesia Market Size by Type
  2. 8.1.1 North America Propofol Injection for Operation General Anesthesia Revenue by Type (2021-2032)
  3. 8.1.2 North America Propofol Injection for Operation General Anesthesia Sales by Type (2021-2032)
  4. 8.1.3 North America Propofol Injection for Operation General Anesthesia Price by Type (2021-2032)
  5. 8.2 North America Propofol Injection for Operation General Anesthesia Market Size by Application
  6. 8.2.1 North America Propofol Injection for Operation General Anesthesia Revenue by Application (2021-2032)
  7. 8.2.2 North America Propofol Injection for Operation General Anesthesia Sales by Application (2021-2032)
  8. 8.2.3 North America Propofol Injection for Operation General Anesthesia Price by Application (2021-2032)
  9. 8.3 North America Propofol Injection for Operation General Anesthesia Market Size by Country
  10. 8.3.1 North America Propofol Injection for Operation General Anesthesia Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Propofol Injection for Operation General Anesthesia Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Propofol Injection for Operation General Anesthesia Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Propofol Injection for Operation General Anesthesia Market Size by Type
  2. 9.1.1 Europe Propofol Injection for Operation General Anesthesia Revenue by Type (2021-2032)
  3. 9.1.2 Europe Propofol Injection for Operation General Anesthesia Sales by Type (2021-2032)
  4. 9.1.3 Europe Propofol Injection for Operation General Anesthesia Price by Type (2021-2032)
  5. 9.2 Europe Propofol Injection for Operation General Anesthesia Market Size by Application
  6. 9.2.1 Europe Propofol Injection for Operation General Anesthesia Revenue by Application (2021-2032)
  7. 9.2.2 Europe Propofol Injection for Operation General Anesthesia Sales by Application (2021-2032)
  8. 9.2.3 Europe Propofol Injection for Operation General Anesthesia Price by Application (2021-2032)
  9. 9.3 Europe Propofol Injection for Operation General Anesthesia Market Size by Country
  10. 9.3.1 Europe Propofol Injection for Operation General Anesthesia Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Propofol Injection for Operation General Anesthesia Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Propofol Injection for Operation General Anesthesia Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Propofol Injection for Operation General Anesthesia Market Size by Type
  2. 10.1.1 China Propofol Injection for Operation General Anesthesia Revenue by Type (2021-2032)
  3. 10.1.2 China Propofol Injection for Operation General Anesthesia Sales by Type (2021-2032)
  4. 10.1.3 China Propofol Injection for Operation General Anesthesia Price by Type (2021-2032)
  5. 10.2 China Propofol Injection for Operation General Anesthesia Market Size by Application
  6. 10.2.1 China Propofol Injection for Operation General Anesthesia Revenue by Application (2021-2032)
  7. 10.2.2 China Propofol Injection for Operation General Anesthesia Sales by Application (2021-2032)
  8. 10.2.3 China Propofol Injection for Operation General Anesthesia Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Propofol Injection for Operation General Anesthesia Market Size by Type
  2. 11.1.1 Asia Propofol Injection for Operation General Anesthesia Revenue by Type (2021-2032)
  3. 11.1.2 Asia Propofol Injection for Operation General Anesthesia Sales by Type (2021-2032)
  4. 11.1.3 Asia Propofol Injection for Operation General Anesthesia Price by Type (2021-2032)
  5. 11.2 Asia Propofol Injection for Operation General Anesthesia Market Size by Application
  6. 11.2.1 Asia Propofol Injection for Operation General Anesthesia Revenue by Application (2021-2032)
  7. 11.2.2 Asia Propofol Injection for Operation General Anesthesia Sales by Application (2021-2032)
  8. 11.2.3 Asia Propofol Injection for Operation General Anesthesia Price by Application (2021-2032)
  9. 11.3 Asia Propofol Injection for Operation General Anesthesia Market Size by Country
  10. 11.3.1 Asia Propofol Injection for Operation General Anesthesia Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Propofol Injection for Operation General Anesthesia Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Propofol Injection for Operation General Anesthesia Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Propofol Injection for Operation General Anesthesia Market Size by Type
  2. 12.1.1 SAMEA Propofol Injection for Operation General Anesthesia Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Propofol Injection for Operation General Anesthesia Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Propofol Injection for Operation General Anesthesia Price by Type (2021-2032)
  5. 12.2 SAMEA Propofol Injection for Operation General Anesthesia Market Size by Application
  6. 12.2.1 SAMEA Propofol Injection for Operation General Anesthesia Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Propofol Injection for Operation General Anesthesia Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Propofol Injection for Operation General Anesthesia Price by Application (2021-2032)
  9. 12.3 SAMEA Propofol Injection for Operation General Anesthesia Market Size by Country
  10. 12.3.1 SAMEA Propofol Injection for Operation General Anesthesia Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Propofol Injection for Operation General Anesthesia Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Propofol Injection for Operation General Anesthesia Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Propofol Injection for Operation General Anesthesia Value Chain Analysis
  2. 13.1.1 Propofol Injection for Operation General Anesthesia Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Propofol Injection for Operation General Anesthesia Production Mode & Process
  6. 13.2 Propofol Injection for Operation General Anesthesia Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Propofol Injection for Operation General Anesthesia Distributors
  9. 13.2.3 Propofol Injection for Operation General Anesthesia Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst